Skip to main content

Advertisement

SpringerLink
Log in

Surgical treatment of hepatocellular carcinoma in China

Surgical techniques, indications, and outcomes

  • Original Article
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Background and aims

Surgery remains the most effective treatment for hepatocellular carcinoma (HCC). While resection and liver transplantation achieve the best outcomes in patients with small HCC, controversy surrounds treatment of large HCC, HCC with portal vein tumor thrombus, and HCC with hypersplenism.

Patient/methods

From January 1988 to December 2002, 2,102 patients with large HCC underwent hepatectomy in our hospital. The traditional resection method was used on 959 patients, after which the improved new method was used on 1,143 patients. Meanwhile, from January 1990 until December 2003, hepatic resection ± thrombectomie has been performed in 438 patients with HCC and portal vein tumor thrombus. Among them, 286 patients showed portal vein tumor thrombus located in the primary and secondary branch of the main portal vein (group A), and 152 patients showed portal vein tumor thrombus (PVTT) involved in the main portal vein (group B). Additionally, out of 204 HCC patients with cirrhotic hypersplenism, 94 patients had hepatectomy and splenectomy, and 100 patients had only hepatectomy without hospital death.

Results

The 3- and 5-year survival after resection of large HCCs (over 5 cm) with improved new method in China was between 50.7 and 58.8% and 27.9 and 38.7%, respectively. Tumor recurrence in the liver within 1 year after hepatic resection + thrombectomie was detected in 45% of group A and in 78.8% in group B. The cumulative 5-year overall survival rates were 18.1% for group A and 0% for group B. The 1-, 3-, and 5-year overall survival in HCC plus portal vein tumor thrombus (PVTT) was 58.7, 22.7, and 18.1%. The hepatectomy/splenectomy group had a 5-year tumor-free survival rate of 37.2% and the hepatectomy group alone had 27.2%.

Conclusion

The new resection methods, hepatic resection + thrombectomy and hepatectomy + splenectomy, are very effective treatments for large HCC, HCC with portal vein tumor thrombus, and HCC with hypersplenism, respectively. Local treatment modalities, e.g. percutaneous ethanol injection, cryosurgery, and radiofrequency ablation as well as microwave coagulation are used in patients with poor liver function in small and large HCCs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lau WY, Ho S, Leung TWT, Chan M, Ho R, Johnson PJ, Li AK (1998) Selective internal radiation therapy for non-resectable hepatocellular carcinoma with intraarterial infusion of yttrium-90 microspheres. Int J Radiat Oncol Biol Phys 40:583–592

    Article  CAS  PubMed  Google Scholar 

  2. Chen XP, Qiu FZ (1983) Current status of the surgical management of primary liver cancer in China. Acta Acad Med Wuhan 3:60–64

    CAS  PubMed  Google Scholar 

  3. Chen XP, Wu ZD, Qiu FZ (2000) The history, present and prospect of the surgical treatment of primary liver cancer in China. Chin J Bases Clin Gen Surg 7:257–258

    Google Scholar 

  4. Wu MC (2002) Clinical and experimental research of primary liver cancer in China. Chin-German J Clin Oncol 1:1–4

    Google Scholar 

  5. Llovet JM, Fuster J, Bruix J (1999) Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 39:1434–1440

    Article  Google Scholar 

  6. Takayama T, Makuuchi M, Hirohashi S, Sakamoto M, Yamamoto J, Shimada K, Kosuge T, Okada S, Takayasu K, Yamasaki S (1998) Early hepatocellular carcinoma as an entity with high rate of surgical cure. Hepatology 28:1241–1246

    Article  CAS  PubMed  Google Scholar 

  7. Fong Y, Sun RL, Jarnagin W, Blumgart LH (1999) An analysis of 412 cases of hepatocellular carcinoma at a western center. Ann Surg 229:790–799

    Article  CAS  PubMed  Google Scholar 

  8. Yao FY, Ferrell L, Bass NM, Watson JJ, Baccetti P, Venook A, Ascher NL, Roberts JP (2001) Liver transplantation for hepatocellular carcinoma: expansion of tumor size limits does not adversely impact survival. Hepatology 33:1394–1403

    Article  CAS  PubMed  Google Scholar 

  9. Chen XP, Qiu FZ, Wu ZD, Zhang BX (2004) Chinese experience with hepatotectomy for huge hepatocellular carcinoma. Br J Surg 91:322–326

    Article  CAS  PubMed  Google Scholar 

  10. Chen XP, Wu ZD, Qiu FZ (1984) An experimental study of the longest tolerable time of the total portal tried occlusion in normothermia in rabbits. Chin J Surg 3:153–155

    Google Scholar 

  11. Chen XP, Wu ZD, Qiu FZ (1989) Clinical observation of long time of the total portal tried occlusion in normothermia in 81 cases. Chin J Surg 9:523–524

    Google Scholar 

  12. Launois B (2000) The intrahepatic glissonian approach to liver resection. In: Blumgart LH, Fong Y (eds) Surgery of the Liver and Biliary Tract. Saunders, London, pp 1698–1703

    Google Scholar 

  13. Chen XP, Wu ZD, Qiu FZ (1999) Right hemihepatectomy of directly tie off afferent and efferent hepatic vessels of the tumor-bearing liver. Chin J Pract Surg 19:678–679

    Google Scholar 

  14. Ando E, Tanaka M, Yamashita F, Kuromatsu R, Yutani S, Fukumori K, Sumie S, Yano Y, Okuda K, Sata M (2002) Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis. Cancer 95:588–595

    Article  PubMed  Google Scholar 

  15. Llovet JM, Bustamante J, Castells A, Vilana R, Aguso Mdel C, Sala M, Bru C, Rodes J, Bruix J (1999) Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 29:62–67

    Article  CAS  PubMed  Google Scholar 

  16. Yamada K, Izaki K, Sugimoto K, Magahara H, Morita Y, Yoden E, Matsumoto S, Soejima T, Sugimura K (2003) Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 57:113–119

    Article  PubMed  Google Scholar 

  17. Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Takashima S (1983) Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 148:397–401

    CAS  PubMed  Google Scholar 

  18. Lee HS, Kim JS, Choi IJ, Chung JW, Park JH, Kim CY (1997) The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal obstruction. A prospective controlled study. Cancer 79:2087–2093

    Article  CAS  PubMed  Google Scholar 

  19. Livraghi T, Grigioni W, Mazziotti A, Sangalli G, Vettori C (1990) Percutaneous ethanol injection of portal thrombosis in hepatocellular carcinoma: a new possible treatment. Tumor 76:394–397

    CAS  Google Scholar 

  20. Sitzmann JV, Abrams R (1993) Improved survival for hepatocellular carcinoma with combination surgery and multimodality treatment. Ann Surg 217:149–154

    CAS  PubMed  Google Scholar 

  21. Yamanaka N, Okamoto E, Fujihara S, Kato T, Fujimoto J, Oriyama T, Mitsunobu M, Toyosaka A, Uematsu K, Yamamoto K (1992) Do the tumor cells of hepatocellular carcinoma dislodge into the portal venous system during hepatic resection? Cancer 70:2263–2267

    CAS  PubMed  Google Scholar 

  22. Yamanaka N, Okamoto E, Toyosaka A, Mitunobu M, Fujihara S, Kato T, Fujimoto J, Oriyama T, Furukawa K, Kawamura E (1990) Prognostic factors after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysis. Cancer 65:1104–1110

    CAS  PubMed  Google Scholar 

  23. Shimada M, Takenaka K, Kawahara N, Kajiyama K, Yamamoto K, Shirabe K, Nishizaki T, Yanaga K, Sugimachi K (1996) Surgical treatment strategy for patients with stage hepatocellular carcinoma. Surgery 119:517–522

    CAS  PubMed  Google Scholar 

  24. Fuster J, Garcia-Valdecasas JC, Grande L, Tabet J, Bruix J, Anglada T, Taura P, Lacy AM, Gonzalez X, Vilana R, Bru C, Sole M, Visa J (1996) Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series. Ann Surg 223:297–302

    Article  CAS  PubMed  Google Scholar 

  25. Fong Y, Sun RL, Jarnagin W, Blumgart LH (1999) An analysis of 412 casses of hepatocellular carcinoma at a western center. Ann Surg 229:790–800

    Article  CAS  PubMed  Google Scholar 

  26. Ikai I, Yamaoka Y, Yamamoto Y, Ozaki N, Sakai Y, Satoh S, Shinkura N, Yamamoto M (1998) Surgical intervention for patients with stage—a hepatocellular carcinoma without lymph node metastasis: proposal as a standard therapy. Ann Surg 227:433–439

    Article  CAS  PubMed  Google Scholar 

  27. Izumi R, Shimizu K, Ii T, Yagi M, Matsui O, Nonomura A, Miyazaki I (1994) Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 106:720–727

    CAS  PubMed  Google Scholar 

  28. Fujii T, Takayasu K, Muramatsu Y, Moriyama N, Wakao F, Kosuge T, Takayama T, Makuuchi M, Yamasaki S, Okazaki N (1993) Hepatocellular carcinoma with portal tumor thrombus: analysis of factors determining prognosis. Jpn J Clin Oncol 23:105–109

    CAS  PubMed  Google Scholar 

  29. Hirai K, Kawazoe Y, Yamashita K, Kumagai M, Tanaka M, Sakai T, Inoue R, Eguchi S, Majima Y, Abe M (1986) Transcatheter partial splenic arterial embolization in patients with hypersplenism: a clinical evaluation as supporting therapy for hepatocellular carcinoma and liver cirrhosis. Hepatogastroenterology 33:105–108

    CAS  PubMed  Google Scholar 

  30. Lokich J, Costello P (1983) Splenic embolization to prevent dose limitation of cancer chemotherapy. Am J Roentgenol 140:159–161

    CAS  Google Scholar 

  31. Yoshimi F, Meigata K, Nagao T, Fukushima S, Uchida H, Wakabayashi T (1994) Hepatocellular carcinoma with a solitary adrenal metastasis and poor hepatic functional reserve: report of a case. Surg Today 24:268–271

    CAS  PubMed  Google Scholar 

  32. Shimada M, Hashizume M, Shirabe K, Takenaka K, Sugimachi K (2000) A new surgical strategy for cirrhotic patients with hepatocellular carcinoma and hypersplenism: performing a hepatectomy after a laparoscopic splenectomy. Surg Endosc 14:127–130

    CAS  PubMed  Google Scholar 

  33. Yoshimi F, Meigata K, Nagao T, Fukushima S, Uchida H, Wakabayashi T (1994) Hepatocellular carcinoma with a solitary adrenal metastasis and poor hepatic functional reserve: report of a case. Surg Today 24:268–271

    CAS  PubMed  Google Scholar 

  34. Sugawara Y, Yamamoto J, Shimada K, Yamasaki S, Kosuge T, Takayama T, Makuuchi M (2000) Splenectomy in patients with hepatocellular carcinoma and hypersplenism. J Am Coll Surg 190:446–450

    Article  CAS  PubMed  Google Scholar 

  35. Aoe T, Okamoto Y, Saito T (1995) Activated macrophages induce structural abnormalities of the T cell receptor-CD3 complex. J Exp Med 181:1881–1886

    Article  CAS  PubMed  Google Scholar 

  36. Ringe B, Pichlmayr R, Wittekind C, Tusch G (1991) Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg 15:270–285

    CAS  PubMed  Google Scholar 

  37. Iwatsuki S, Gordon RD, Shaw BW Jr, Starzl TE (1985) Role of liver transplantation in cancer therapy. Ann Surg 202:401–407

    CAS  PubMed  Google Scholar 

  38. O’Grady JG, Polson RJ, Rolles K, Calne RY, Williams R (1988) Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg 207:373–379

    CAS  PubMed  Google Scholar 

  39. Ismail T, Angrisani L, Gunson BK, Hubscher G, Buckels JAC, Neuberger JM, Elias E, McMaster P (1990) Primary hepatic malignancy. The role of liver transplantation. Br J Surg 77:983–987

    CAS  PubMed  Google Scholar 

  40. Pichlmayr R, Weimann A, Ringe B (1994) Indications for liver transplantation in hepatobiliary malignancy. Hepatology 20:33S–40S

    Article  CAS  PubMed  Google Scholar 

  41. Bismuth H, Chiche L, Castaing D (1995) Surgical treatment of hepatocellular carcinomas in non-cirrhotic liver: experience with 68 liver resections. World J Surg 19:35–41

    Article  CAS  PubMed  Google Scholar 

  42. Schwartz M, Sung M, Mor E, Fisher A, Popescu I, Fiel I, Sheiner P, Emre S, Guy S, Miller CM (1995) A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis. J Am Coll Surg 180:596–603

    CAS  PubMed  Google Scholar 

  43. Mazzafero V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabtto A, Gennari L (1996) liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. N Engl J Med 334:693–699

    Article  PubMed  Google Scholar 

  44. Mcpeake JR, O’Grady JG, Zaman S, Portmann B, Wight DGD, Tan KC, Calne RY, Williams R (1993) liver transplantation for primary hepatocellular carcinoma: tumor size and number determine outcome. J Hepatol 18:226–234

    Article  CAS  PubMed  Google Scholar 

  45. Dmitrewski J, El-Gazzaz G, McMaster P (1998) Hepatocellular cancer: resection or transplantation. J Hepatol Bil Pancr Surg 5:18–23

    CAS  Google Scholar 

  46. Castells A, Bruix J, Bru C, Ayuso C, Roca M, Boix L, Vilane R, Rodes J (1993) Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology 18:1121–1126

    Article  CAS  PubMed  Google Scholar 

  47. Ohnishi K (1998) Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatogastroenterology 45:1254–1258

    CAS  PubMed  Google Scholar 

  48. Adam R, Akpinar E, Johann M, Kunstlinger F, Majno P, Bismuth H (1997) Place of cryosurgery in the treatment of malignant liver tumors. Ann Surg 225:39–50

    Article  CAS  PubMed  Google Scholar 

  49. Zhou XD, Tang ZY (1998) Cryotherapy for primary liver cancer. Semin Surg Oncol 14:171–174

    Article  CAS  PubMed  Google Scholar 

  50. Pearson AS, Izzo F, Fleming D, Ellis LM, Delrio P, Roh MS, Granchi J, Curley SA (1999) Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg 178:592–599

    Article  CAS  PubMed  Google Scholar 

  51. Buscarini L, Rossi S (1997) Technology for radiofrequency thermal ablation of liver tumors. Semin Laparosc Surg 4:96–101

    PubMed  Google Scholar 

  52. Murakami R, Yoshimatsu S, Yamashita Y, Matsukawa T, Takahashi M, Sagara K (1995) Treatment of hepatocellular carcinoma: value of percutaneous microwave coagulation. AJR Am J Roentgenol 164:1159–1164

    CAS  Google Scholar 

  53. Song SB, Zhang TL, Xiu DR, Yuan J, Wang DC, Jiang B, Wang CM (2004) Effective evaluation of liver transplantation for hepatocellular carcinoma. Zhonghua Yi Xue Za Zhi 84:1533–1535

    PubMed  Google Scholar 

  54. Xu X, Zheng SS, Liang TB, Wang WL, Jin J, Shen Y, Wu J, Yu J (2004) Orthotopic liver transplantation for patients with hepatocellular carcinoma complicated by portal vein tumor thrombi. Hepatobiliary Pancreat Dis Int 3:341–344

    PubMed  Google Scholar 

  55. Zhao JC, Lu SC, Yan LN, Li B, Wen TF, Zeng Y, Cheng NS, Wang J, Luo Y, Pen YL (2003) Incidence and treatment of hepatic artery complications after orthotopic liver transplantation. World J Gastroenterol 9:2853–2855

    PubMed  Google Scholar 

  56. Chen ZS, Zeng FJ, Ming CS, Lin ZB, Zhang WJ, Wei L, Zhu XH, Jiang JP, Chen ZK (2004) The survival and value of liver transplantation for liver carcinoma: a single-center experience. Transplant Proc 36:2284–2286

    Article  CAS  PubMed  Google Scholar 

  57. Lencioni R, Cioni D, Crocetti L, Bartolozzi C (2004) Percutaneous ablation of hepatocellular carcinoma: state-of-the-art. Liver Transpl 10:S91–S97

    Article  PubMed  Google Scholar 

  58. Wong WS, Patel SC, Cruz FS, Gala KV, Turner AF (1998) Cryosurgery as a treatment for advanced stage hepatocellular carcinoma: results, complications, and alcohol ablation. Cancer 82:1268–1278

    Article  CAS  PubMed  Google Scholar 

  59. Zhou X, Tang Z, Yu Y (1996) Long-term results of multimodality treatment in patients with primary liver cancer. Zhonghua Wai Ke Za Zhi 34:518–521

    CAS  PubMed  Google Scholar 

  60. Yin XY, Xie XY, Lu MD, Chen JW, Xu HX, Xu ZF, Liu GJ, Huang B (2004) Ultrasound-guided percutaneous composite thermal ablation technique in treatment of medium and large hepatocellular carcinoma. Zhonghua Wai Ke Za Zhi 42:1029–1032

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, People’s Republic of China

    Xiao-Ping Chen & Zhi-Yong Huang

Authors
  1. Xiao-Ping Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhi-Yong Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xiao-Ping Chen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, XP., Huang, ZY. Surgical treatment of hepatocellular carcinoma in China. Langenbecks Arch Surg 390, 259–265 (2005). https://doi.org/10.1007/s00423-005-0552-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-005-0552-9

Keywords

Search

Navigation